publication venue for
- The role of alpha-synuclein in synucleinopathy: Impact on lipid regulation at mitochondria-ER membranes.. 11:-. 2025
- IC100 blocks inflammasome activation induced by α-synuclein aggregates and ASC specks.. 11:-. 2025
- Circulating blood circular RNA in Parkinson's Disease; from involvement in pathology to diagnostic tools in at-risk individuals.. 10:-. 2024
- Grey matter networks in women and men with dementia with Lewy bodies.. 10:-. 2024
- Genetic analysis of the X chromosome in people with Lewy body dementia nominates new risk loci.. 10:-. 2024
- Differences in brain aging between sexes in Parkinson's disease.. 10:-. 2024
- Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson's disease.. 9:-. 2023
- Optical pulse labeling studies reveal exogenous seeding slows α-synuclein clearance.. 8:-. 2022
- Il-10 signaling reduces survival in mouse models of synucleinopathy.. 7:-. 2021
- The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism.. 7:-. 2021
- Protection from α-Synuclein induced dopaminergic neurodegeneration by overexpression of the mitochondrial import receptor TOM20.. 6:-. 2020
- Acquired dysregulation of dopamine homeostasis reproduces features of Parkinson's disease.. 6:-. 2020
- Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson's disease.. -. 2019
- Advance care planning in Parkinson's disease: ethical challenges and future directions.. -. 2019